Fertility clinics can now use a new test to predict IVF success
What happened
US health regulators have made it easier to bring a new type of fertility test to market. This means doctors and patients will have more options to predict the success of in-vitro fertilization (IVF) treatments.
Why it matters
For years, fertility clinics relied on a limited set of tools to assess a woman's ovarian reserve and predict IVF outcomes. This regulatory change opens the door for new diagnostic tests to be widely adopted. It means patients undergoing IVF may get more precise information about their chances of success, potentially reducing the emotional and financial burden of multiple failed cycles.
The signal
Watch for new anti-Mullerian hormone (AMH) test systems to appear on the market and for fertility clinics to begin offering them as a standard part of IVF consultation.